What are the recommended dosing regimens of sumatriptan (oral, nasal spray, and subcutaneous) for an adult with acute migraine, including maximum daily limits?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Sumatriptan Dosing for Acute Migraine in Adults

For acute migraine treatment in adults, use sumatriptan 50-100 mg orally (maximum 200 mg/24 hours), 6 mg subcutaneously (may repeat once after 1 hour, maximum 12 mg/24 hours), or 20 mg intranasal spray (maximum 40 mg/24 hours), with subcutaneous administration providing the fastest and most effective relief.

Oral Sumatriptan Dosing

The FDA-approved oral doses are 25 mg, 50 mg, or 100 mg 1. Evidence demonstrates that:

  • 50 mg and 100 mg provide greater efficacy than 25 mg
  • 100 mg does NOT provide significantly greater effect than 50 mg but carries higher adverse event risk 2, 1
  • Start with 50 mg for most patients as the optimal balance of efficacy and tolerability
  • If headache returns or partial response occurs, may repeat dose after 2 hours
  • Maximum daily dose: 200 mg in 24 hours 2, 1

Hepatic Impairment Consideration

In patients with mild-to-moderate hepatic impairment, do not exceed 50 mg single dose due to unpredictable elevations in bioavailability 2, 1.

Subcutaneous Sumatriptan Dosing

The recommended dose is 6 mg subcutaneously 3, 4. This route provides:

  • Fastest onset of action among all formulations
  • Highest efficacy: NNT of 2.0 for pain-free at 1 hour (compared to 3.0 for oral at 2 hours) 5
  • 73% headache relief rate at 1 hour with 6 mg dose 3
  • The 8 mg dose showed similar efficacy to 6 mg but with more adverse events 3
  • May repeat once after 1 hour if needed
  • Maximum: 12 mg in 24 hours (two 6 mg doses)

Use subcutaneous route for severe attacks or when nausea/vomiting precludes oral administration 6.

Intranasal Sumatriptan Dosing

The recommended dose is 20 mg (single spray in one nostril) 7. Key characteristics:

  • 20 mg significantly superior to 5 mg and 10 mg doses at 2 hours (64% vs 46-49% headache relief) 7
  • 42% pain-free rate at 2 hours with 20 mg dose 7
  • Efficacy comparable to oral sumatriptan but with faster onset than oral 5
  • May repeat after 2 hours if needed
  • Maximum: 40 mg in 24 hours

Route Selection Algorithm

  1. Subcutaneous (6 mg): Use for severe attacks, rapid relief needed, or presence of severe nausea/vomiting 6, 8

  2. Oral (50-100 mg): First-line for moderate-to-severe attacks without severe nausea 6

  3. Intranasal (20 mg): Alternative when oral not tolerated or faster onset desired than oral 7

Critical Timing and Combination Guidance

  • Treat early during mild pain phase for better outcomes 9
  • Combine with NSAID or acetaminophen for enhanced efficacy per 2025 ACP guidelines 6
  • After initial subcutaneous dose, may use oral sumatriptan (up to 100 mg/day) with at least 2-hour interval 2, 1

Medication Overuse Headache Warning

Limit sumatriptan use to ≤10 days per month to prevent medication overuse headache 6. This threshold is lower than NSAIDs (≤15 days/month).

Contraindications

Do NOT use with MAO-A inhibitors - causes unpredictable elevations in sumatriptan bioavailability 2.

Comparative Efficacy Summary

Based on systematic review data 5:

  • Subcutaneous 6 mg: NNT 2.0 at 1 hour (most effective, fastest)
  • Oral 100 mg: NNT 4.7 at 2 hours
  • Intranasal 20 mg: NNT 3.1 at 2 hours

Subcutaneous causes more adverse events (NNT for harm 3.0) compared to oral (NNT 8.3), but events are typically transient and mild 5, 4.

Related Questions

What is the appropriate sumatriptan dosing for acute migraine in an elderly patient, including safety considerations and contraindications?
What are the recommended sumatriptan dosing guidelines for acute migraine treatment in adults and adolescents, including oral, subcutaneous, and nasal spray formulations, and what precautions are needed for elderly patients, those with hepatic impairment, or those taking monoamine‑oxidase inhibitors?
What is the recommended duration of acute sumatriptan therapy for migraine?
Is sumatriptan an abortive medication for acute migraine attacks?
What is the recommended low-dose sumatriptan regimen for acute migraine, including dosing, repeat‑dose limits, contraindications, and alternative therapies?
How should a patient with a tender lateral neck mass, recent cough, upper‑respiratory symptoms, and undocumented fever be evaluated and managed?
What are the differential diagnoses for a patient with a tender lateral neck mass, recent cough and upper‑respiratory symptoms, and undocumented fever?
Is it safe to co‑administer aspirin (typically 81 mg daily) with acetazolamide, and what monitoring of renal function and electrolytes is recommended?
What is the recommended duration of acute sumatriptan therapy for migraine?
When should oral feeding be initiated after an exploratory laparotomy?
In a patient receiving maintenance IV fluids (60–100 mL/hr) after ERCP sphincterotomy with stone extraction and biliary stent placement, currently on ceftriaxone, can inflammation cause hemoconcentration?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.